KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Short term Debt: 2023-2025

Historic Short term Debt for Rigel Pharmaceuticals (RIGL) over the last 1 years, with Sep 2025 value amounting to $29.8 million.

  • Rigel Pharmaceuticals' Short term Debt was N/A to $29.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.8 million, marking a year-over-year change of. This contributed to the annual value of $7.3 million for FY2024, which is 0.59% up from last year.
  • According to the latest figures from Q3 2025, Rigel Pharmaceuticals' Short term Debt is $29.8 million, which was up 33.09% from $22.4 million recorded in Q2 2025.
  • Rigel Pharmaceuticals' 5-year Short term Debt high stood at $29.8 million for Q3 2025, and its period low was $7.2 million during Q4 2023.
  • In the last 3 years, Rigel Pharmaceuticals' Short term Debt had a median value of $14.8 million in 2024 and averaged $16.0 million.
  • Data for Rigel Pharmaceuticals' Short term Debt shows a peak YoY increased of 0.59% (in 2024) over the last 5 years.
  • Over the past 3 years, Rigel Pharmaceuticals' Short term Debt (Quarterly) stood at $7.2 million in 2023, then increased by 0.59% to $7.3 million in 2024, then rose by 0.24% to $29.8 million in 2025.
  • Its Short term Debt was $29.8 million in Q3 2025, compared to $22.4 million in Q2 2025 and $14.8 million in Q1 2025.